Masayuki Miyasaka Selected Research

Masayuki Miyasaka Research Topics

Disease

18	Neoplasms (Cancer) 04/2022 - 08/2002
9	Inflammation (Inflammations) 01/2019 - 04/2002
6	Neoplasm Metastasis (Metastasis) 04/2022 - 08/2002
3	Rheumatoid Arthritis 10/2014 - 01/2002
2	Fibrosis (Cirrhosis) 01/2017 - 01/2012
2	Infections 08/2014 - 10/2006
2	Arthritis (Polyarthritis) 08/2013 - 01/2010
2	Ureteral Obstruction 01/2004 - 04/2003
1	Breast Neoplasms (Breast Cancer) 04/2022
1	Lymphatic Metastasis 04/2022
1	Vasculitis (Vasculitides) 01/2019
1	Colonic Neoplasms (Colon Cancer) 11/2018
1	Pathologic Processes 01/2017
1	Eosinophilia 01/2017
1	Pulmonary Fibrosis (Fibrosing Alveolitis) 01/2017
1	Osteoarthritis 10/2014
1	Experimental Arthritis 10/2014
1	Peritonitis 08/2014
1	Chronic Hepatitis (Chronic Active Hepatitis) 01/2012
1	Hepatitis C 01/2012
1	Hepatocellular Carcinoma (Hepatoma) 01/2012
1	Fatty Liver 01/2012
1	Chronic Hepatitis C 01/2012
1	Crohn Disease (Crohn's Disease) 02/2011
1	Colitis 02/2011
1	Thymoma (Thymic Carcinoma) 02/2010
1	Atrophy 09/2009
1	Osteosarcoma (Osteogenic Sarcoma) 07/2009
1	Wounds and Injuries (Trauma) 09/2008
1	Hypereosinophilic Syndrome (Loeffler Endocarditis) 01/2008
1	Catalepsy 11/2007
1	Atherosclerosis 02/2007
1	Lymphadenopathy 07/2003

Drug/Important Bio-Agent (IBA)

9	ChemokinesIBA 04/2022 - 04/2003
6	CytokinesIBA 04/2022 - 01/2002
6	Hyaluronic Acid (Hyaluronan)IBA 05/2010 - 11/2002
6	OligosaccharidesIBA 01/2010 - 11/2002
5	L-SelectinIBA 12/2008 - 11/2002
4	Proteins (Proteins, Gene)FDA Link 01/2022 - 09/2002
4	Monoclonal AntibodiesIBA 11/2018 - 11/2002
3	LigandsIBA 04/2022 - 11/2002
3	LipidsIBA 01/2019 - 08/2002
3	lysophosphatidic acidIBA 01/2019 - 08/2013
3	Lysophosphatidic Acid ReceptorsIBA 01/2019 - 08/2013
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2012 - 09/2002
3	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 02/2010 - 09/2002
3	Chondroitin Sulfates (Chondroitin Sulfate)IBA 07/2009 - 08/2002
2	Collagen Type II (Type II Collagen)IBA 08/2013 - 01/2010
2	Therapeutic UsesIBA 01/2012 - 11/2002
2	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 02/2011 - 09/2002
2	Biological ProductsIBA 02/2011 - 03/2006
2	P-SelectinIBA 09/2008 - 11/2002
2	SelectinsIBA 04/2003 - 11/2002
1	Rituximab (Mabthera)FDA Link 01/2022
1	Immune Checkpoint InhibitorsIBA 11/2020
1	Neoplasm Antigens (Tumor Antigens)IBA 11/2020
1	Chemotactic FactorsIBA 01/2019
1	cytidylyl-(3'-5')-cytidine (CpC)IBA 11/2018
1	AntibodiesIBA 12/2017
1	AminesIBA 01/2017
1	Bleomycin (Blenoxane)FDA LinkGeneric 01/2017
1	CollagenIBA 01/2017
1	Oxidoreductases (Dehydrogenase)IBA 01/2017
1	Chemokine ReceptorsIBA 01/2017
1	Messenger RNA (mRNA)IBA 10/2014
1	Integrin alpha4beta1 (VLA-4)IBA 08/2014
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 08/2013
1	GlycogenIBA 01/2012
1	InterleukinsIBA 01/2012
1	Poly CIBA 01/2012
1	AcidsIBA 01/2012
1	Interleukin-6 (Interleukin 6)IBA 01/2012
1	Etanercept (Enbrel)FDA Link 02/2011
1	Interleukin-17 (Interleukin 17)IBA 02/2011
1	InterferonsIBA 02/2011
1	PaxillinIBA 02/2010
1	chondroitin sulfate E hexasaccharideIBA 01/2010
1	Interleukin-15 (Interleukin 15)IBA 09/2009
1	Glutens (Glutelin)IBA 09/2009
1	Heparitin Sulfate (Heparan Sulfate)IBA 07/2009
1	Dermatan SulfateIBA 07/2009
1	P-selectin ligand proteinIBA 12/2008
1	Cell Adhesion MoleculesIBA 05/2008
1	RacloprideIBA 11/2007
1	Cocaine (Cocaine HCl)IBA 11/2007
1	SK&F 81297IBA 11/2007
1	Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA 02/2007
1	NF-kappa B (NF-kB)IBA 02/2007
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 02/2007
1	PolymersIBA 03/2006
1	Tissue Inhibitor of Metalloproteinase-2IBA 02/2004
1	Metalloproteases (Metalloproteinases)IBA 02/2004
1	KB R7785IBA 02/2004
1	galactosylceramide sulfotransferaseIBA 01/2004
1	AntigensIBA 07/2003
1	Collagen Type XVIII (Type XVIII Collagen)IBA 04/2003

Therapy/Procedure

5	Therapeutics 01/2019 - 11/2002
4	Immunotherapy 01/2022 - 11/2010
1	Ligation 08/2014
1	Punctures 08/2014